August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Antibody–drug conjugates improve outcomes for patients with inoperable or metastatic Breast Cancer – European Society for Medical Oncology
Oct 26, 2023, 17:00

Antibody–drug conjugates improve outcomes for patients with inoperable or metastatic Breast Cancer – European Society for Medical Oncology

ESMO – European Society for Medical Oncology shared a post on LinkedIn:

“Antibody–drug conjugates improve outcomes for patients with inoperable or metastatic Breast Cancer.
At ESMO23, a Presidential Symposium presentation of TROPION-Breast01 trial showed that datopotamab deruxtecan significantly improved PFS compared to chemotherapy in previously treated patients with HR+/HER2- disease.
Also, updated survival data from the DESTINY-Breast04 trial indicate a sustained OS benefit in patients with HER2-low disease treated with trastuzumab deruxtecan.

On the ESMO Daily Reporter, check out the full data from the two studies commented by Sarat Chandarlapaty, New York, USA.”

For details click here.
Source: ESMO – European Society for Medical Oncology/LinkedIn